January 28, 2010ALBUQUERQUE, N.M. – OsoBio will sponsor the Biologics Forum at the Drug, Chemical & Associated Technologies Association (DCAT) in March.
The forum, “The Rapid Evolution of BioManufacturing and the New Supplier Reality” will take place Wednesday, March 17, from 1:30 to 4:15 p.m. with a networking reception taking place shortly afterward at the Waldorf-Astoria Hotel in New York City.
“As a biopharmaceutical manufacturing company renowned for our quality assurance and ability to handle complex projects, OsoBio is proud to support this educational seminar on ensuring effective biologic manufacturing,” said Stuart Rose, president and CEO of OsoBio.
OSO BioPharmaceuticals Manufacturing LLC is a contract manufacturing organization for biologic and pharmaceutical injectables. Headquartered in Albuquerque, N.M., OsoBio specializes in products requiring complex handling, including highly potent compounds. Responsiveness, attention to detail and clear communication are the hallmarks of our client care.
OsoBio surpasses quality–assurance expectations within our industry. Our employees are industry veterans who provide innovative solutions to our clients’ most difficult projects.